Indivior Inc. v. Teva Pharmaceuticals USA, Inc.
1:16-cv-00178
Overview
Parties
Defendant
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
0 Attorneys ListedCounter Defendant
Indivior UK Limited NPE (University / Research)
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 20 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| π¨π³ China | China Counterpart | View Official Patent → | |
| π¨π³ China | China Counterpart | View Official Patent → | |
| π°π· South Korea | South Korea Counterpart | View Official Patent → | |
| π°π· South Korea | South Korea Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8475832
Sublingual and buccal film compositions
|
Filed: 2009-08-07
Issued: 2013-07-02
|
Active (3.3 yrs remaining)
+231d PTA
Expires: 2030-03-26
|
|
|
US8017150
Polyethylene oxide-based films and drug delivery systems made therefrom
|
Filed: 2008-04-22
Issued: 2011-09-13
|
Expired (Term Ended)
Expires: 2023-10-10
|
|
|
US8603514
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
Filed: 2007-07-10
Issued: 2013-12-10
|
Expired (Term Ended)
Expires: 2024-04-03
|
|
|
US8900497
Process for making a film having a substantially uniform distribution of components
|
Filed: 2013-08-23
Issued: 2014-12-02
|
Active (6.8 yrs remaining)
Expires: 2033-08-23
|
|
|
US8906277
Process for manufacturing a resulting pharmaceutical film
|
Filed: 2013-08-23
Issued: 2014-12-09
|
Active (6.8 yrs remaining)
Expires: 2033-08-23
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+231 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
1
Granted
1
Denied
0
Pending / Review
0
Motions by Category
Key Dispositive Motions & Rulings